Center-Authored Papers

Filters: Author is Hanash, Samir M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Amon LM, Pitteri SJ, Li CI, McIntosh MW, Ladd J, Disis ML, Porter PL, Wong C-H, Zhang Q, Prentice RL et al..  2012.  Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.. Cancer research. Abstract
B
Baird BN, Schliekelman MJ, Ahn Y-H, Chen Y, Roybal JD, Gill BJ, Mishra DK, Erez B, O'Reilly M, Yang Y et al..  2013.  Fibulin-2 is a driver of malignant progression in lung adenocarcinoma.. PloS one. 8(6):e67054. Abstract
C
Capello M, Lee M, Wang H, Babel I, Katz MH, Fleming JB, Maitra A, Wang H, Tian W, Taguchi A et al..  2015.  Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.. Journal of the National Cancer Institute. 107(8) Abstract
Creighton CJ, Nagaraja AK, Hanash SM, Matzuk MM, Gunaratne PH.  2008.  A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions.. RNA (New York, N.Y.). 14(11):2290-6. Abstract
E
Ehrlich M, Sanchez C, Shao C, Nishiyama R, Kehrl J, Kuick R, Kubota T, Hanash SM.  2008.  ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation.. Autoimmunity. 41(4):253-71. Abstract
F
Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ et al..  2008.  A mouse to human search for plasma proteome changes associated with pancreatic tumor development.. PLoS medicine. 5(6):e123. Abstract
Faça VM, Hanash SM.  2009.  In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding.. Cancer research. 69(3):728-30. Abstract
Faça VM, Ventura AP, Fitzgibbon MP, Pereira-Faça SR, Pitteri SJ, Green AE, Ireton RC, Zhang Q, Wang H, O'Briant KC et al..  2008.  Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.. PloS one. 3(6):e2425. Abstract
Faca V, Wang H, Hanash SM.  2009.  Proteomic global profiling for cancer biomarker discovery.. Methods in molecular biology (Clifton, N.J.). 492:309-20. Abstract
Fang Q, Kani K, Faca VM, Zhang W, Zhang Q, Jain A, Hanash SM, Agus DB, McIntosh MW, Mallick P.  2011.  Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma.. PloS one. 6(7):e23090. Abstract
Fang Q, Strand A, Law W, Faca VM, Fitzgibbon MP, Hamel N, Houle B, Liu X, May DH, Poschmann G et al..  2009.  Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease.. Molecular & cellular proteomics : MCP. 8(3):451-66. Abstract
G
Garcia J, Faca V, Jarzembowski J, Zhang Q, Park J, Hanash SM.  2009.  Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation.. Journal of proteome research. 8(8):3791-6. Abstract
H
Hanash SM.  2011.  Why have protein biomarkers not reached the clinic? Genome medicine. 3(10):66.
Hanash SM, Pitteri SJ, Faca VM.  2008.  Mining the plasma proteome for cancer biomarkers.. Nature. 452(7187):571-9. Abstract
Hanash SM, Baik CS, Kallioniemi O.  2011.  Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.. Nature reviews. Clinical oncology. 8(3):142-50. Abstract
Hanash SM, Taguchi A.  2010.  The grand challenge to decipher the cancer proteome.. Nature reviews. Cancer. 10(9):652-60. Abstract
Hanash SM.  2011.  Progress in mining the human proteome for disease applications.. Omics : a journal of integrative biology. 15(3):133-9. Abstract
Hanash SM.  2011.  Harnessing the immune response for cancer detection.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(4):569-70.
Hansen JA, Hanash SM, Tabellini L, Baik C, Lawler RL, Grogan BM, Storer BE, Chin A, Johnson M, Wong C-H et al..  2013.  A Novel Soluble Form of Tim-3 Associated with Severe Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(9):1323-30. Abstract
Harsha HC, Kandasamy K, Ranganathan P, Rani S, Ramabadran S, Gollapudi S, Balakrishnan L, Dwivedi SB, Telikicherla D, Selvan LDN et al..  2009.  A compendium of potential biomarkers of pancreatic cancer.. PLoS medicine. 6(4):e1000046.
Hung KE, Faca V, Song K, Sarracino DA, Richard LG, Krastins B, Forrester S, Porter A, Kunin A, Mahmood U et al..  2009.  Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis.. Cancer prevention research (Philadelphia, Pa.). 2(3):224-33. Abstract
J
Jeong S-K, Kwon M-S, Lee E-Y, Lee H-J, Cho SY, Kim H, Yoo JS, Omenn GS, Aebersold R, Hanash SM et al..  2009.  BiomarkerDigger: a versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers.. Proteomics. 9(14):3729-40. Abstract
K
Katayama H, Paczesny S, Prentice RL, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J et al..  2009.  Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings.. Genome medicine. 1(4):47. Abstract
Kelly-Spratt KS, Pitteri SJ, Gurley KE, Liggitt D, Chin A, Kennedy J, Wong C-H, Zhang Q, Busald Buson T, Wang H et al..  2011.  Plasma proteome profiles associated with inflammation, angiogenesis, and cancer.. PloS one. 6(5):e19721. Abstract
Kim Y-S, Son OL, Lee JY, Kim SH, Oh S, Lee YS, Kim C-H, Yoo JS, Lee J-H, Miyoshi E et al..  2008.  Lectin precipitation using phytohemagglutinin-L(4) coupled to avidin-agarose for serological biomarker discovery in colorectal cancer.. Proteomics. 8(16):3229-35. Abstract